H. D. Dincyurek Et Al. , "First use of plasmapheresis in the treatment of T cell engaging therapies related adverse effects," 9th International Eurasian Hematology Oncology Congress (EHOC) , vol.73, İstanbul, Turkey, 2018
Dincyurek, H. D. Et Al. 2018. First use of plasmapheresis in the treatment of T cell engaging therapies related adverse effects. 9th International Eurasian Hematology Oncology Congress (EHOC) , (İstanbul, Turkey).
Dincyurek, H. D., Mutlu, Y. G., Sahin, B., Ertop, S., & Guvenc, B., (2018). First use of plasmapheresis in the treatment of T cell engaging therapies related adverse effects . 9th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Turkey
Dincyurek, H. Et Al. "First use of plasmapheresis in the treatment of T cell engaging therapies related adverse effects," 9th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Turkey, 2018
Dincyurek, H. D. Et Al. "First use of plasmapheresis in the treatment of T cell engaging therapies related adverse effects." 9th International Eurasian Hematology Oncology Congress (EHOC) , İstanbul, Turkey, 2018
Dincyurek, H. D. Et Al. (2018) . "First use of plasmapheresis in the treatment of T cell engaging therapies related adverse effects." 9th International Eurasian Hematology Oncology Congress (EHOC) , İstanbul, Turkey.
@conferencepaper{conferencepaper, author={H. D. Dincyurek Et Al. }, title={First use of plasmapheresis in the treatment of T cell engaging therapies related adverse effects}, congress name={9th International Eurasian Hematology Oncology Congress (EHOC)}, city={İstanbul}, country={Turkey}, year={2018}}